New Anti-Malaria Vaccine Reduces Risk Of Infection By Over 70 Percent

New Anti-Malaria Vaccine Reduces Risk Of Infection By Over 70 PercentAn effective anti-malaria vaccine has been developed by a team of researchers at the Osaka University Research Institute for Microbial Diseases in Japan. The results of clinical trials conducted over a two-year period on location in Uganda, Africa, and published in the U.S. journal PLOS One confirm the BK-SE36 dry powder vaccine lowered the risk of acquiring malaria by a whopping 72 percent.